Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions

Vaccination Clinical Trial

Official title:

Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02231957
• Other study ID #: AAAM3756
• Status: Completed
• Phase: N/A
• First received: August 15, 2014
• Last updated: January 27, 2017
• Start date: July 2014
• Est. completion date: January 2017

Study information

• Verified date: January 2017
• Source: Columbia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

There are a growing number of adolescents with chronic medical conditions in the United States. The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination and annual influenza vaccination of all adolescents. Pneumococcal polysaccharide vaccination is also recommended for certain high-risk patients. Limited studies suggest that vaccination coverage of this population remains sub-optimal. Text message vaccine reminder/recall has been shown to be effective in increasing uptake of select pediatric and adolescents vaccines, but has yet to be examined among patients with chronic medical conditions who may also face unique barriers to vaccination. This intervention aims to implement and evaluate the use of text message vaccine reminders among urban low-income minority adolescents with chronic medical conditions. This investigator-initiated study is supported in part by a grant from the Pfizer Medical Education Group.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 416
• Est. completion date: January 2017
• Est. primary completion date: June 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 11 Years and older

Eligibility

Inclusion Criteria:

Parent with

1. adolescent aged 11-17 years;

2. adolescent with =1 chronic medical condition;

3. adolescent with clinic visit in last 12 months;

4. cell phone number listed in hospital registration system

Exclusion Criteria:

Parent who:

1. does not speak English or Spanish;

2. is unwilling to receive text message vaccine reminders;

3. anticipates moving from area in coming 12 months

Related Conditions & MeSH terms

• Vaccination

Intervention

Other:
• educational text message reminders

• conventional text message reminders

Locations

Country	Name	City	State
United States	NewYork-Presbyterian Hospital/Columbia University Medical Center	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Columbia University	Pfizer

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)		12 weeks after intervention start
Secondary	Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)		4 weeks after intervention start
Secondary	Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)		24 weeks after intervention start
Secondary	Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination		4 weeks after intervention start
Secondary	Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination		12 weeks after intervention start
Secondary	Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination		24 weeks after intervention start